This protocol is judged by an institutional evaluate board, an independent group that reviews any clinical trials involving people. If a study consists of a Program I drug, after the board approves the protocol as moral, the scientists need to make an application for an investigational new drug (IND) number in the FDA.If This is often The 1st time